Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
12 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Rezolute, Inc.’s names, not what it holds today.
Patents granted
12
12 utility, 1976 to Dec 31, 2025
Granted in 2025
1
in the last year the record reads
Applications published
16
since 2001, to Dec 31, 2025
Names they are printed under
4
its own name, a former name
By yearGrantedApplications published
'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
Rezolute, Inc. its own name
US, as the owner printed on each patent
3 publishedANTRIABIO, INC. a former name
US, as the owner printed on each patent
4 publishedRezolute, Inc. its own name
named as the applicant on its applications, in US
5 publishedAntriaBio, Inc. a former name
named as the applicant on its applications, in US
4 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Mar 4, 2025 | 12,240,818 | Crystalline forms of plasma kallikrein inhibitors | Organic fine chemistry | Rezolute, Inc. |
| Apr 19, 2022 | 11,306,061 | Crystalline forms of plasma kallikrein inhibitors | Organic fine chemistry | Rezolute, Inc. |
| Mar 8, 2022 | 11,267,790 | Processes for preparing plasma kallikrein inhibitors | Organic fine chemistry | Rezolute, Inc. |
| Jul 7, 2020 | 10,702,611 | Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates | Pharmaceuticals | Rezolute, Inc. |
| Feb 18, 2020 | 10,561,620 | Coiled tube emulsification systems | Chemical engineering | Rezolute, Inc. |
| Mar 5, 2019 | 10,220,075 | Amine pegylation methods for the preparation of site-specific protein conjugates | Pharmaceuticals | Rezolute, Inc. |
| Nov 27, 2018 | 10,137,089 | Solvent extraction from biodegradable microparticles | Pharmaceuticals | Rezolute, Inc. |
| Aug 14, 2018 | 10,046,058 | Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates | Pharmaceuticals | Rezolute, Inc. |
| Oct 17, 2017 | 9,789,196 | Site-specific insulin-polymer conjugates | Pharmaceuticals | ANTRIABIO, INC. |
| Jan 3, 2017 | 9,532,953 | Solvent extraction from biodegradable microparticles | Pharmaceuticals | ANTRIABIO, INC. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Jun 6, 2024 | 2024/0182427 | SOLID DOSAGE FORMS OF A PLASMA KALLIKREIN INHIBITOR | Pharmaceuticals | Rezolute, Inc. |
| Jul 27, 2023 | 2023/0234927 | PROCESSES FOR PREPARING PLASMA KALLIKREIN INHIBITORS | Organic fine chemistry | Rezolute, Inc. |
| Dec 1, 2022 | 2022/0380315 | CRYSTALLINE FORMS OF PLASMA KALLIKREIN INHIBITORS | Organic fine chemistry | Rezolute, Inc. · patent 12,240,818 granted from it |
| Jan 14, 2021 | 2021/0009526 | PROCESSES FOR PREPARING PLASMA KALLIKREIN INHIBITORS | Organic fine chemistry | Rezolute, Inc. · patent 11,267,790 granted from it |
| Jan 14, 2021 | 2021/0009525 | CRYSTALLINE FORMS OF PLASMA KALLIKREIN INHIBITORS | Organic fine chemistry | Rezolute, Inc. · patent 11,306,061 granted from it |
| Apr 30, 2020 | 2020/0129443 | COILED TUBE EMULSIFICATION METHODS | Chemical engineering | Rezolute, Inc. |
| Mar 21, 2019 | 2019/0083412 | COILED TUBE EMULSIFICATION SYSTEMS AND METHODS | Chemical engineering | ANTRIABIO, INC. · patent 10,561,620 granted from it |
| Nov 8, 2018 | 2018/0318429 | USE OF HYDROPHOBIC ORGANIC ACIDS TO INCREASE HYDROPHOBICITY OF PROTEINS AND PROTEIN CONJUGATES | Pharmaceuticals | Rezolute, Inc. · patent 10,702,611 granted from it |
| Sep 27, 2018 | 2018/0271792 | ORAL DELIVERY OF PHYSIOLOGICALLY ACTIVE SUBSTANCES | Pharmaceuticals | Rezolute, Inc. |
| Mar 16, 2017 | 2017/0071860 | SOLVENT EXTRACTION FROM BIODEGRADABLE MICROPARTICLES | Pharmaceuticals | ANTRIABIO, INC. · patent 10,137,089 granted from it |
What it applied for, 2024 to 2025: Pharmaceuticals 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.